|
Synonyms: Andervi® | APL 502 | APL502 | TQB-2450 | TQB2450
benmelstobart is an approved drug
Compound class:
Antibody
Comment: Benmelstobart (TQB2450) is a fully humanised anti-programmed cell death 1 ligand 1 (PD-L1) monoclonal antibody. It was developed to treat advanced solid tumours by blocking the inhibitory the PD-1/PD-L1/L2 immune checkpoint.
|
| Bioactivity Comments |
| We have been unable to uncover quantitative data that supports antibody binding to its proposed target. |
| Selectivity at ligand targets | ||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
